Firms

Sanofi Ventures

Sanofi Ventures is Sanofi’s corporate venture investment arm, backing biotechnology, AI and digital-health companies globally from seed through later private rounds and IPO participation. Its evergreen strategy focuses on immunology, rare diseases, neurology and vaccines, while supporting companies with board involvement and access to Sanofi’s scientific, clinical, regulatory, manufacturing and commercial capabilities. Sanofi announced an additional $625 million multi-year commitment on September 24, 2025, bringing reported assets under management above $1.4 billion; this was corporate evergreen funding, rather than a separately closed external LP fund.

Founded: —
Type: Venture capital

Funds1

Sanofi Ventures evergreen fund2025-09-242025-09-24—
Sanofi’s corporate evergreen venture fund invests from seed through crossover in biotechnology and digital health, including AI-enabled healthcare, immunology, rare diseases, neurology and vaccines. On September 24, 2025, Sanofi announced an additional multi-year $625 million commitment to this existing evergreen fund to expand investment capacity. This is an expansion of an established corporate vehicle rather than a separately closed $625 million externally raised fund. Its exact current fund corpus is not disclosed: more than $1.4 billion assets under management and more than $800 million historically deployed are aggregate figures and are not used as an exact fund amount. The date records the expansion announcement, not the original 2012 launch or an inferred closing day.

Team

Operations and support

Anne JammalExecutive Assistant

Chris GagliardiPrincipal

Cris De LucaPartner

Francesc Dosrius LleonartAssociate Director of Investments

Jason P. HaflerManaging Director

Kriti SubramanyamDirector of Investments

Laia CrespoPartner

Meg KrenchPrincipal

Paulina HillPartner

Pierre GaudeauxAssociate Director of Investments

Rebecca GorelovAssociate Director of Investments

Steve BychowskiGeneral Counsel

Investments

$380M2026-09-08	Korsana Biosciences	Sanofi Ventures
$73M2026-06-22	Nura Bio	Sanofi Ventures, Samsara BioCapital
$150M2026-02-18	Korsana Biosciences	Sanofi Ventures
$—2025-09-17	Character Biosciences	Sanofi Ventures
$115M2025-04-16	Glycomine	abrdn Inc., Advent Life Sciences, CTI Life Sciences Fund, Novo Holdings, Sanofi Ventures, Abingworth LLP, RiverVest Venture Partners, Remiges Ventures, Chiesi Ventures, Asahi Kasei Ventures, Sanderling Ventures
$93M2025-03-25	Character Biosciences	Luma Group, S32, Innovation Endeavors, Casdin Capital, Catalio Capital Management, aMoon, Sanofi Ventures, Jefferson Life Sciences
$97M2025-01-28	Atalanta Therapeutics	EQT Life Sciences, Sanofi Ventures, RiverVest Venture Partners, Novartis Venture Fund, Mirae Asset, F-Prime Capital, GHR Foundation, Pictet Alternative Advisors, abrdn Inc.
$68M2024-09-17	Nura Bio	Sanofi Ventures
$73M2021-07-09	Muna Therapeutics	Novo Holdings, Droia Ventures, Sanofi Ventures, V-Bio Ventures, VIB (Flanders Institute for Biotechnology)
$35M2021-06-23	Glycomine	Abingworth LLP, Sanofi Ventures, RiverVest Venture Partners, Remiges Ventures, Novo Holdings, Mission BioCapital, Chiesi Ventures, Sanderling Ventures
$—2025-11-19	Lifordi Immunotherapeutics	ARCH Venture Partners, Atlas Venture, Sanofi Ventures, AMD Ventures
$80M2025-10-28	Zag Bio	Lightspeed, Bowery Capital, ReGen Ventures, Sanofi Ventures, Koch Disruptive Technologies, Mission BioCapital, Pear VC
$140M2025-06-18	Draig Therapeutics	Access Biotechnology, SV Health Investors, Canaan Partners, SR One, Sanofi Ventures, Schroders Capital
$200M2025-02-12	Abcuro, Inc.	Bain Capital, New Enterprise Associates, Sanofi Ventures, Mass General Brigham Ventures, Pontifax, New Leaf Venture Partners
$250M2025	Mirador Therapeutics	ARCH Venture Partners, Alexandria Venture Investments, Logos Capital, Farallon Capital Management, Sanofi Ventures, Venrock Healthcare Capital Partners
$372M2024-11-06	Formation	Sequoia, FPV Ventures, Andreessen Horowitz, Thrive Capital, Emerson Collective, Sanofi Ventures
$372M2024-06-26	Formation Bio	Sequoia, FPV Ventures, Thrive Capital, SV Angel, Emerson Collective, Sanofi Ventures
$400M2024-03-21	Mirador Tx	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Logos Capital, Sanofi Ventures, Blue Owl Healthcare Opportunities
$147M2023-12-20	Sudo Biosciences	Enavate Sciences, TPG, Sanofi Ventures, Surveyor Capital, Monograph Capital, Eventide Asset Management, Frazier Life Sciences, Dementia Discovery Fund, Leaps by Bayer, UPMC Enterprises
$30M2023-12-05	Eligo Bioscience	Khosla Ventures, Sanofi Ventures, Bpifrance, Seventure Partners, Samir Kaul
$88M2023-03-09	QurAlis	Droia Ventures, EQT Life Sciences, Sanofi Ventures, INKEF Capital, Dementia Discovery Fund, Mission BioCapital, Polaris Innovation Fund, Amgen Ventures, ALS Investment Fund, Sanford Biosciences LLC, MP Healthcare Venture Management, Dolby Family Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Inc.
$—2022-11-22	Empatica	Sanofi Ventures, RA Capital Management, Black Opal Ventures
$52M2021-10-22	Click Therapeutics	H.I.G. HealthBridge (formerly H.I.G. BioHealth Partners), Accelmed Partners, Sanofi Ventures, K2 HealthVentures, Hikma Ventures, Revelation Partners, Health Catalyst Capital, Ridgetop Health
$30M2021-02-25	Medisafe	OurCrowd, Qualcomm Ventures, Octopus Ventures, Sanofi Ventures, Triventures, ALIVE
$—2018-07-23	Click Therapeutics	Sanofi Ventures
$75M2015-08-11	Ovid Therapeutics	Fidelity Management & Research Company, Cowen Healthcare Investments, Sanofi Ventures, Tekla Capital Management, Jennison Associates, Redmile Group, Cormorant Asset Management
$60M2012-07-25	bluebird bio	ARCH Venture Partners, Sanofi Ventures, Forbion, Deerfield, Third Rock Ventures
$315MUnknown date	AdvanCell	Bain Capital, Catalio Capital Management, T. Rowe Price, Alpha Wave Global, Sanofi Ventures, Eventide Asset Management
$200MUnknown date	Abcuro	Bain Capital, Cormorant Asset Management, Sanofi Ventures, Mass General Brigham Ventures, Samsara BioCapital, Pontifax
$72MUnknown date	Rome	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Y Combinator, Sanofi Ventures, Mass General Brigham Ventures
$75MUnknown date	Areteia Therapeutics	ARCH Venture Partners, Maverick Ventures, Viking Global Investors, GV, Alphabet Inc., Bain Capital, Sanofi Ventures
$30M2023-12-05	Eligo	Khosla Ventures, Sanofi Ventures, Bpifrance, Seventure Partners, Vesper Holding

Funds1

Team

Operations and support

Co-investing

Investments